(NASDAQ: CELZ) Creative Medical Technology Holdings's forecast annual revenue growth rate of 1,263.58% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 55.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.2%.
Creative Medical Technology Holdings's revenue in 2025 is $14,000.On average, 1 Wall Street analysts forecast CELZ's revenue for 2025 to be $7,756,596, with the lowest CELZ revenue forecast at $7,756,596, and the highest CELZ revenue forecast at $7,756,596. On average, 1 Wall Street analysts forecast CELZ's revenue for 2027 to be $87,468,548, with the lowest CELZ revenue forecast at $87,468,548, and the highest CELZ revenue forecast at $87,468,548.
In 2028, CELZ is forecast to generate $178,427,563 in revenue, with the lowest revenue forecast at $178,427,563 and the highest revenue forecast at $178,427,563.